Continued Improvement of Signs and Symptoms in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study.

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
McInnes, Iain B. [2 ]
Gottlieb, Alice B. [3 ]
Puig, Lluis [4 ]
Rahman, Proton [5 ]
Ritchlin, Christopher T. [6 ]
Li, Shu [7 ]
Wang, Yuhua [7 ]
Doyle, Mittie K. [7 ]
Mendelsohn, Alan M. [7 ]
机构：
[1] UCSD Sch Med, La Jolla, CA USA
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Tufts Med Ctr, Boston, MA USA
[4] Univ Autonoma Barcelona, Barcelona, Spain
[5] Mem Univ Newfoundland, St John, NF, Canada
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L4
引用
收藏
页码：4168 / 4168
页数：1
相关论文
共 50 条
  • [21] A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study.
    Kavanaugh, Arthur
    Decktor, Dennis L.
    Fan, Chunpeng
    van Adelsberg, Janet
    Martincova, Renata
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1233 - S1234
  • [22] Effect of Certolizumab Pegol On Signs and Symptoms in Patients with Psoriatic Arthritis with and without Prior Anti-TNF Exposure: 24 Week Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study
    Mease, Philip
    Fleischmann, Roy M.
    Wollenhaupt, Juergen
    Deodhar, Atul A.
    Kielar, Danuta
    Woltering, Franz
    Stach, Christian
    Hoepken, Bengt
    Arledge, Terri
    van der Heijde, Desiree
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1107 - S1107
  • [23] Ustekinumab in Active Psoriatic Arthritis Including Patients Previously Treated with Anti-TNF Agents: Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Ritchlin, Christopher T.
    Gottlieb, Alice B.
    McInnes, Iain B.
    Puig, Lluis
    Rahman, Proton
    Li, Shu
    Wang, Yuhua
    Doyle, Mittie K.
    Mendelsohn, Alan
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1080 - S1081
  • [24] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
  • [25] Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study
    Leng, Xiaomei
    Lin, Wei
    Liu, Shixue
    Kanik, Keith
    Wang, Cunshan
    Wan, Weiguo
    Jiang, Zhenyu
    Liu, Yi
    Liu, Shengyun
    Zhang, Zhuoli
    Zhang, Zhiyi
    Xu, Jian
    Tan, Wenfeng
    Hu, Jiankang
    Li, Jingyang
    Liu, Ju
    Gunay, Levent M.
    Dina, Oluwaseyi
    Kinch, Cassandra
    Zeng, Xiaofeng
    RMD OPEN, 2023, 9 (01):
  • [26] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS
    CARETTE, S
    CALIN, A
    MCCAFFERTY, JP
    WALLIN, BA
    ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 158 - 165
  • [27] Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylarthritis As Well As Peripheral Arthritis: Results from 2 Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Kavanaugh, Arthur
    Puig, Luis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    You, Yin
    Li, Shu
    Song, Michael
    Randazzo, Bruce
    Rahman, Proton
    McInnes, Iain. B.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [28] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136): : 2213 - 2224
  • [29] EFFICACY AND SAFETY OF USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS WITH SPONDYLITIS AND PERIPHERAL JOINT INVOLVEMENT: RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    You, Y.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 136 - 136
  • [30] SULFASALAZINE IN PSORIATIC-ARTHRITIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    FARR, M
    KITAS, GD
    WATERHOUSE, L
    JUBB, R
    FELIXDAVIES, D
    BACON, PA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1990, 29 (01): : 46 - 49
12345